scispace - formally typeset
J

J. T. Merrill

Researcher at Oklahoma Medical Research Foundation

Publications -  19
Citations -  1487

J. T. Merrill is an academic researcher from Oklahoma Medical Research Foundation. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 9, co-authored 11 publications receiving 1263 citations.

Papers
More filters
Journal ArticleDOI

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

Ian N. Bruce, +39 more
TL;DR: It is found that several potentially modifiable risk factors for damage accrual are identified and an integrated strategy to address these may improve long-term outcomes.
Journal ArticleDOI

Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study

TL;DR: Regardless of attribution, the occurrence of NP events was associated with reduced quality of life and increased organ damage, and those with NP events had lower scores on the SF-36 and higher SDI scores compared with patients with no NP events.
Journal ArticleDOI

Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus

TL;DR: NP events in patients with SLE are of variable frequency, most commonly present early in the disease course and adversely impact patients' quality of life over time, although the latter have a more favourable outcome.
Journal ArticleDOI

Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study

TL;DR: Seizures occurred close to SLE diagnosis, in patients with African race/ethnicity, lower educational status and cumulative organ damage, and there was an association with disease activity but not with autoantibodies.
Journal ArticleDOI

Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus

TL;DR: LA and anti-ribosomal P antibodies are associated with an increased future risk of intracranial thrombosis and lupus psychosis, respectively.